Tested Applications
| Positive WB detected in | Raji cells, Daudi cells |
| Positive IHC detected in | human tonsillitis tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:2000-1:16000 |
| Immunohistochemistry (IHC) | IHC : 1:250-1:1000 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
26949-1-AP targets FCRLA in WB, IHC, ELISA applications and shows reactivity with human samples.
| Tested Reactivity | human |
| Cited Reactivity | human |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag25331 Product name: Recombinant human FCRLA protein Source: e coli.-derived, PGEX-4T Tag: GST Domain: 275-376 aa of BC006521 Sequence: IRVQGASSSAAPPTLNPAPQKSAAPGTAPEEAPGPLPPPPTPSSEDPGFSSPLGMPDPHLYHQMGLLLKHMQDVRVLLGHLLMELRELSGHQKPGTTKATAE Predict reactive species |
| Full Name | Fc receptor-like A |
| Calculated Molecular Weight | 39 kDa |
| Observed Molecular Weight | 39-43 kDa |
| GenBank Accession Number | BC006521 |
| Gene Symbol | FCRLA |
| Gene ID (NCBI) | 84824 |
| RRID | AB_2880697 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | Q7L513 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Protocols
| Product Specific Protocols | |
|---|---|
| IHC protocol for FCRLA antibody 26949-1-AP | Download protocol |
| WB protocol for FCRLA antibody 26949-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
FCRLA Polyclonal antibody (26949-1-AP) has 1 citation total. It appears in the journal Int J Cancer (2025, impact factor 4.9). The research field associated with this citation is colorectal oncology, specifically investigating tumor deposits in colorectal cancer and their aggressive characteristics, with implications for staging refinement in patients with 0–3 metastatic lymph nodes. The antibody was used in IHC applications on human samples.
| Species | Application | Title |
|---|---|---|
Int J Cancer Aggressive characteristics of tumor deposits in colorectal cancer highlight the need for staging refinement in patients with 0-3 metastatic lymph nodes |











